Here, we investigated whether allo-HCT contributes to atherosclerosis by establishing a novel mouse model using a minor histocompatibility antigen (miHAg) mismatch transplant approach in atherosclerosis-prone LDL receptor-deficient (Ldlr−/−) mice. Here, LDLR is linked to atherosclerosis.